Skip to content

Urgent urology symptoms What to do

Putting the Spotlight on Membranous Nephropathy

Urology TodayPublished November 11, 20105 min read

Key points

  • The Halpin Foundation and the American Society of Nephrology (ASN) proudly highlight the research advances in membranous nephropathy made possible by The Halpin Foundation-ASN Research Grant, created to help young faculty develop independent research careers.
  • The 2009 recipient of The Halpin Foundation Laurence H.
  • Beck and several colleagues will also participate in a Clinical Nephrology Conference (CNC) during Renal Week entitled, “Membranous Nephropathy” on Friday, November 19 from 10:30 am – 12:30 pm in Korbel 2A/3A of the Colorado Convention Center in Denver, CO.
  • The foundation is committed to advancing the medical community’s understanding of membranous nephropathy, including whether there is a hereditary predisposition to the disease.

The Halpin Foundation and the American Society of Nephrology (ASN) proudly highlight the research advances in membranous nephropathy made possible by The Halpin Foundation-ASN Research Grant, created to help young faculty develop independent research careers. This award provides recipients transition funding toward successful application for an NIH RO1 grant.

Elena Torban, PhD (McGill University Faculty of Medicine), the 2008 recipient of The Halpin Foundation- ASN Research Grant, recently explained, “The generous financial two-year support provided by The Halpin Foundation has enabled us to conduct a successful experimental program demonstrating for the first time that podocyte architecture is indeed regulated by the PCP pathway. We also showed that the podocyte-specific protein, nephrin, is linked to proteins of the PCP network. This finding establishes a mechanism whereby the PCP pathway regulates nephrin-dependent organization of foot processes.”

The 2009 recipient of The Halpin Foundation Laurence H. Beck, Jr., MD, PhD wrote of the grant, “The funding provided by the Halpin Foundation has been instrumental in allowing my research to take root and grow.

The research award has permitted me to spend the majority of these two years in the laboratory, performing experiments and helping to train young scientists and fellows conduct similar lines of inquiry. The fruits of this research should soon allow me to successfully apply for individual federal funding. Their ongoing interactions with leaders in this field on a national and international level have been enormously helpful for me in terms of forming productive collaborations to move this research forward. I will always be grateful for this support at such a critical time in the career of a young physician-scientist.”

Dr. Beck and several colleagues will also participate in a Clinical Nephrology Conference (CNC) during Renal Week entitled, “Membranous Nephropathy” on Friday, November 19 from 10:30 am – 12:30 pm in Korbel 2A/3A of the Colorado Convention Center in Denver, CO. The session, “The Human Membranous Antibody: Mechanism and Monitoring” is a way to highlight research advances and stimulate investigations regarding membranous nephropathy.

The Halpin Foundation has dedicated itself to the study of membranous nephropathy since 1989, after the Halpins’ 14-year-old son was diagnosed with this rare disorder. To advance research of the disorder and its symptoms, including loss of protein in the urine and a progressive decline in renal function, The Halpin Foundation partnered with the American Society of Nephrology (ASN) to promote research relevant to membranous nephropathy in 2004.

The foundation is committed to advancing the medical community’s understanding of membranous nephropathy, including whether there is a hereditary predisposition to the disease. In addition, The Halpin Foundation works to raise awareness of membranous nephropathy in the scientific and lay communities.

“We are grateful to The Halpin Foundation for helping us fund new investigators interested in studying this disease to answer the many unanswered questions surrounding membranous nephropathy and nephrotic syndrome, said ASN’s President, Sharon Anderson, MD, FASN.

Joan Halpin, President of the Halpin Foundation, is hopeful this program will “attract a diverse audience that will be encouraged to devote time and intellect to the consideration of the pathogenesis and therapy for this disorder.”

# # #

ASN Renal Week 2010, the largest nephrology meeting of its kind, will provide a forum for 13,000 professionals to discuss the latest findings in renal research and engage in educational sessions related to advances in the care of patients with kidney and related disorders. Renal Week 2010 will take place November 16 – November 21 at the Colorado Convention Center in Denver, CO.

The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.

Founded in 1966, the American Society of Nephrology (ASN) is the world’s largest professional society devoted to the study of kidney disease. Comprised of 11,000 physicians and scientists, ASN continues to promote expert patient care, to advance medical research, and to educate the renal community. ASN also informs policymakers about issues of importance to kidney doctors and their patients. ASN funds research, and through its world-renowned meetings and first-class publications, disseminates information and educational tools that empower physicians.

###

Source: American Society of Nephrology (ASN)

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. If you cannot pass urine, have a fever with back or side pain, or sudden severe pain in the testicle, call 911 or go to an emergency department.

Urinary symptoms?

Weak stream, urgency, up at night? Score it in two minutes.

Seven questions from the International Prostate Symptom Score show whether symptoms are mild, moderate or severe, and when to see a doctor.

Take the symptom score

When to get help

Most urology problems can wait for an appointment. These can’t.

Call 911 or go to an emergency department if you have any of these:

  • You cannot pass urine at allAcute urinary retention: a painful, swollen bladder. It needs a catheter, often within hours.
  • Fever or chills with back or side painA blocked, infected kidney (for example behind a stone) can turn into sepsis quickly.
  • Sudden, severe pain in a testiclePossible testicular torsion. The testicle can often be saved only within about 6 hours.
  • An erection lasting over 4 hoursPriapism. Without treatment it can cause permanent damage.
Call 911

Outside the US, call your local emergency number.

See a doctor within days

  1. 01Blood in your urineEven once, and even without pain. Usually harmless, but it is the most common first sign of bladder and kidney cancer.
  2. 02Burning, frequent or cloudy urineTypical of a urinary tract infection, which usually clears with treatment.
  3. 03A lump or swelling in a testicleMost lumps are benign; testicular cancer is very treatable when found early.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.